Medulloblastoma
Showing NaN - NaN of 10
High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))
Recruiting
- High Grade Glioma
- +12 more
- LUTATHERA® (Lutetium Lu 177 dotatate)
-
Aurora, Colorado
- +8 more
Jan 16, 2023
CNS Tumors, Medulloblastoma Trial in Worldwide (Pomalidomide)
Active, not recruiting
- Central Nervous System Neoplasms
- Medulloblastoma
-
Stanford, California
- +24 more
Sep 28, 2022
Desmoplastic/Nodular Medulloblastoma, Medulloblastoma, Medulloblastoma With Extensive Nodularity Trial in Worldwide
Active, not recruiting
- Desmoplastic/Nodular Medulloblastoma
- +4 more
- Carboplatin
- +6 more
-
Birmingham, Alabama
- +172 more
Jan 4, 2022
Medulloblastoma, Pineoblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified Trial in United States (radiation, drug,
Completed
- Medulloblastoma
- +2 more
- 3-Dimensional Conformal Radiation Therapy
- +10 more
-
Los Angeles, California
- +14 more
Jan 12, 2022
Anaplastic Medulloblastoma, Medulloblastoma Trial in Worldwide (drug, biological, other, radiation)
Active, not recruiting
- Anaplastic Medulloblastoma
- Medulloblastoma
- Carboplatin
- +8 more
-
Birmingham, Alabama
- +195 more
Jan 4, 2022
Teratoid Tumor, Atypical, Choroid Plexus Tumors, Anaplastic Astrocytoma Trial in United States (azurin-derived cell-penetrating
Completed
- Teratoid Tumor, Atypical
- +9 more
- azurin-derived cell-penetrating peptide p28
-
Los Angeles, California
- +10 more
Aug 3, 2017